Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19

• Published in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 27; no. 6; pp. 808 - 813
• Main Authors: Kutsuna, Satoshi, Asai, Yusuke, Matsunaga, Akihiro, Kinoshita, Noriko, Terada, Mari, Miyazato, Yusuke, Nakamoto, Takato, Suzuki, Tetsuya, Saito, Sho, Endo, Mio, Kanda, Kohei, Kenji, Maeda, Takasaki, Jin, Hojo, Masayuki, Ishizaka, Yukihito, Ohmagari, Norio
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.06.2021; Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd
• Subjects: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-SARS-CoV-2 spike protein antibody; Antibodies, Viral - immunology; Antibody Formation; Convalescent; COVID-19; COVID-19 - immunology; Female; Humans; Immunoglobulin G - immunology; Male; Middle Aged; Original; SARS-CoV-2; Spike Glycoprotein, Coronavirus - immunology; COVID-19; SARS-CoV-2; Anti-SARS-CoV-2 spike protein antibody; Convalescent

Among patients with coronavirus disease 2019 (COVID-19), the factors that affect anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody production remain unclear. This study aimed to identify such factors among patients convalescing from COVID-19. This study comprised patients wh...